Diagnosis and treatment of adrenocorticotrophic hormone-independent macronodular adrenocortical hyperplasia: A report of 23 cases in a single center
- Authors:
- Published online on: December 8, 2014 https://doi.org/10.3892/etm.2014.2115
- Pages: 507-512
Abstract
Introduction
Adrenocorticotrophic hormone (ACTH)-independent macronodular adrenal hyperplasia (AIMAH) is a rare disorder characterized by bilateral macronodular hyperplasia of the adrenal glands and increased cortisol production with subclinical or overt Cushing’s syndrome (CS) (1,2). AIMAH represents <1% of cases of endogenous CS; however, since 10% of adrenal lesions are bilateral, AIMAH with subclinical cortisol secretion is becoming increasingly recognized (3). Patients with AIMAH are diagnosed following incidental radiological observations or the investigation of an adrenal over-secretion syndrome (4,5). AIMAH usually presents without symptoms, although in a number of cases patients are diagnosed following clinical CS.
The most common cause (95% of patients) of AIMAH is adrenocortical adenoma or carcinoma. The majority of the remaining patients have primary pigmented nodular adrenal disease, a syndrome that is characterized by multiple small bilateral pigmented adrenocortical nodules, and is often associated with the Carney complex (6). The diagnosis and management of patients with ACTH-independent CS and bilateral adrenal masses are problematic (7,8), particularly for bilateral adrenal adenomas. In the current study, a total of 23 AIMAH cases are presented; the patients were admitted to the Tianjin Medical University General Hospital (Tianjin, China) between July 1994 and 2010, and diagnosed by pathology.
Materials and methods
Patients
The present study was approved and registered by the Ethics Committee of the Tianjin Medical University General Hospital (Tianjin, China) in January 1993. The Ethics Committee approved all associated screening, treatment, data collection and follow-up of the patients; written informed consent was obtained from all particpants. All experiments were undertaken in accordance with the Declaration of Helsinki. A total of 23 patients (males, 14; females, 9; mean age, 49 years) were admitted to the Tianjin Medical University General Hospital between July 1994 and 2010. All the patients presented with several symptoms characteristic of CS, and hypertension was observed during examination. The duration of the disease ranged between one and five years. Diabetes occurred in 10 cases (10/23), central obesity occurred in eight cases, a sanguine appearance was observed in six cases and 14 patients exhibited purple stripes on their body.
The levels of plasma cortisol, ACTH and urinary free cortisol (UFC) were analyzed in all the patients using DPC Immulite 2000 (Siemens Healthcare, Los Angeles, CA, USA), and patients were subjected to high and low dose dexamethasone suppression tests (HDDST and LDDST). Plasma cortisol levels were monitored in these patients, Magnetic resonance imaging (MRI) examinations (Discovery MR750w 3.0T; GE Healthcare, Pittsburgh, PA, USA) and computed tomography (CT) scans (Lightspeed VCT XT; GE Healthcare) were also performed.
Operative procedures
Bilateral adrenalectomy was performed in eight patients and unilateral adrenalectomy was performed in 15 patients. The surgical procedures were performed as previously described by Shinbo et al (9). Briefly, under general anesthesia, patients undergoing a right adrenalectomy were placed in a left lateral position. Next, 10/12-mm trocars were placed at the mid-clavicular line below the costal margin and at the median line 5 cm above the umbilicus, while 5-mm trocars were placed at approximately three finger-widths below the xyphoid process and at the anterior axillary line 5 cm below the costal margin. Laparosonic coagulating shears with a suction and irrigation device and with a cautery and L-hook tip were used when necessary. The two trocars at the median line remained on the abdominal wall while skin wounds at the other trocar sites were closed.
For left laparoscopic adrenalectomy, patients were repositioned in a right half lateral position, and two 5-mm trocars were placed at the left region of the costal margin and at the midclavicular line below the costal margin. The left adrenal gland was isolated similarly to right side and enclosed in an endoscopic pouch. Skin wounds were closed.
Results
Laboratory testing results
Results of the HDDST and LDDST were negative. Four patients received plasma cortisol rhythm determination, while the plasma cortisol levels in the additional 19 cases were only examined at 8:00 am. The results demonstrated that plasma cortisol levels were elevated in 20 patients. In addition, the levels of UFC were increased, while the levels of ACTH were decreased in the 23 patients (Table I).
Imaging examination
MRI examinations revealed that the pituitary gland was normal in 17 patients; however, MRI of the pituitary gland was not performed in the remaining six patients. Observations from the CT scans revealed bilateral adrenal nodules of soft tissue density, measuring ≤5 cm, and irregular nodular masses in the adrenal glands. In addition, the CT scans demonstrated that the adrenal lesions with macronodularity were significantly enlarged (Fig. 1), and the largest diameter of an adrenal nodular was 6 cm.
Surgery and discharge
Following surgery, all the resected samples were confirmed positive by histopathological analysis (Fig. 2). The nodules were observed as bright cells under the light microscope and the normal cortical structure had disappeared. The general clinical and biochemical conditions of the patients are summarized in Table II. Lumbar open surgery was performed in nine patients, retroperitoneal laparoscopic surgery was performed in seven patients, single abdominal open surgery were performed in three patients, multiple lumbar open surgery was performed in two patients and laparoscopic surgery was performed in two patients. Infection occurred in one patient following surgery, which was controlled following treatment. The resected adrenal nodular mass in all the patients was a diffused grayish yellow or golden yellow color (Fig. 3). The largest nodular was 6×4×4 cm, weighing 40 g and with no clear coat covering the resected adrenal tissue. The surface of the resected slide was golden brown and had a diameter of 0.6–1.7 cm. Patients with unilateral resection were not treated with hormone drug therapy at discharge; however, bilateral resection patients received 5 or 10 mg prednisone treatment.
Postoperative follow-up
Following surgery, hypertension of the patients was significantly alleviated. The eight patients who underwent bilateral adrenalectomy were followed-up for 2–8 years and were treated with glucocorticoid replacement therapy. The patients had normal blood pressure, breathing rate returned to the normal level, and the obesity and sanguine appearance was alleviated.
Decreased blood pressure following surgery was observed in 15 patients. However, after three years, 12 of the 15 patients had hypertension of ~150–170/90–100 mmHg, which was maintained at 130–150/70–85 mmHg following oral administration of antihypertensive drugs. The additional three patients (cases 11, 12 and 23) had no response to oral antihypertensive drugs and their blood pressure reached 170–180/90–110 mmHg. Plasma cortisol, UFC, ACTH and CT analyses were performed, and the contralateral adrenal gland was found to have increased to 35, 32 and 38 ml, respectively. The blood pressure of these patients returned to normal following the removal of the contralateral adrenal gland and hormone replacement therapy. Nelson’s syndrome was not observed following therapy.
Discussion
CS is caused by excessive cortisol secretion and is associated with increased mortality and severe morbidity. The condition is not fully reversible, despite biochemical control. CS is characterized by the loss of normal feedback regulation and circadian rhythm of the hypothalamic-pituitary axis due to inappropriate secretion of ACTH from a pituitary tumor (Cushing’s disease) or an ectopic source (ectopic ACTH secretion). The remaining causes (20%) are ACTH independent. Once a diagnosis is established, the therapeutic goal is the removal of the tumor. Whenever surgery is not curative, the management of patients with CS requires a major effort to control hypercortisolemia and the associated symptoms (10).
The diagnosis of CS is based on the clinical features of hypercortisolism, the absence of serum cortisol diurnal rhythm, elevated midnight sleeping cortisol levels and incomplete cortisol suppression test (11). CS due to AIMAH was first reported in an isolated case (12).
AIMAH is characterized by bilateral macronodular hyperplasia of the adrenal glands and is one of the causes of CS (13). Clinical manifestations include hypertension, weight gain, impaired glucose tolerance or diabetes mellitus, osteoporosis and an increased susceptibility to bruising. Hypogonadism and gynecomastia have been reported in males and hirsutism in females (14). The precise etiology of AIMAH is unknown; however, previous studies have demonstrated that aberrant adrenal expression and aberrant function of a number of peptide hormone receptors, including receptors for glucose-dependent insulinotropic hormone, vasopressin, luteinizing hormone/human chorionic gonadotropin, β-adrenergic agonists and serotonin, may lead to adrenal cell proliferation and abnormal regulation of steroidogenesis in AIMAH (15,16).
Cross-sectional imaging is commonly used to identify adrenal disease in patients with CS. CT and MRI scans are used to document the lesion size and shape, presence or absence of calcification, hemorrhage and necrosis. With regard to MRI, T1-weighted images are hypointense relative to the liver and isointense relative to muscle, while T2-weighted images tend to be hyperintense relative to the liver (17,18). By contrast, the nodules of patients with chronic ACTH stimulation appear isointense relative to the liver on T2-weighted MRI scans (19).
Histological analysis revealed a marked increase in the number of small clear cells, which are predominantly derived from the upper fascicular zone. The amount of cortisol produced by each cell is small; thus, significant enlargement of the adrenal gland is necessary before excessive cortisol production causes CS (20). The definitive treatment of CS consists of surgical resection of the tumor secreting ACTH. When the source of excessive cortisol secretion is the pituitary gland, the standard approach is to perform an endoscopic endonasal trans-sphenoidal exploration, with excision of the tumor if identified. This surgical procedure is demanding and should only be performed in centers with extensive experience to minimize the surgical risks, reduce the possibility of remission and maintain other pituitary gland functions.
Bilateral adrenalectomy via an overt or laparoscopic approach is the most useful treatment for patients with AIMAH and hormonal hypersecretion (21,22). However, in patients exhibiting moderately increased hormonal production, unilateral adrenalectomy is proposed as a safe and effective alternative; it is expected that as the cell mass increases in the contralateral adrenal gland, a second adrenalectomy may be required (23,24).
In conclusion, a total of 23 cases diagnosed with AIMAH were presented in the current study. High and low dose dexamethasone failed to suppress cortisone secretion in the suppression tests and ACTH levels were low in all the cases. Bilateral enlarged adrenal glands were observed on CT scans, and bilateral adrenal macronodular hyperplasia was confirmed in all the cases by pathological examination. In accordance with previous studies (25,26), the results of the present study demonstrated that AIMAH had unique endocrinological, radiological and pathological features. Diagnosis of AIMAH is predominantly derived from pathological examination and long term remission may be achieved by unilateral adrenalectomy. Contralateral adrenalectomy should be performed in cases of recurrence, when followed with periodical examination of the symptoms and serum concentration of cortisol.
References
Bertagna X, Guignat L, Groussin L and Bertherat J: Cushing’s disease. Best Pract Res Clin Endocrinol Metab. 23:607–623. 2009. View Article : Google Scholar : PubMed/NCBI | |
Goñi Iriarte MJ: Cushing’s syndrome: special issues. Endocrinol Nutr. 56:251–261. 2009.(In Spanish). View Article : Google Scholar | |
Lacroix A: ACTH-independent macronodular adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 23:245–259. 2009. View Article : Google Scholar : PubMed/NCBI | |
Bourdeau I, D’Amour P, Hamet P, Boutin JM and Lacroix A: Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing’s syndrome. J Clin Endocrinol Metab. 86:5534–5540. 2001.PubMed/NCBI | |
Yamada Y, Sakaguchi K, Inoue T, et al: Preclinical Cushing’s syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of gluco- and mineralocorticoids. Intern Med. 36:628–632. 1997. View Article : Google Scholar : PubMed/NCBI | |
Stratakis CA, Carney JA, Lin JP, et al: Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. 97:699–705. 1996. View Article : Google Scholar : PubMed/NCBI | |
Karapanou O, Vlassopoulou B, Tzanela M, Stratigou T, Tsatlidis V and Tsirona S: Adrenocorticotropic hormone independent macronodular adrenal hyperplasia due to aberrant receptor expression: is medical treatment always an option? Endocr Pract. 19:e77–e82. 2013. View Article : Google Scholar : PubMed/NCBI | |
Yoshida M, Umeda H, Iwama S, et al: Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia. Endocrine. 41:160–161. 2012. View Article : Google Scholar | |
Shinbo H, Suzuki K, Sato T, Kageyama S, Ushiyama T and Fujita K: Simultaneous bilateral laparoscopic adrenalectomy in ACTH-independent macronodular adrenal hyperplasia. Int J Urol. 8:315–318. 2001. View Article : Google Scholar : PubMed/NCBI | |
Pozza C, Graziadio C, Giannetta E, Lenzi A and Isidori AM: Management strategies for aggressive cushing’s syndrome: from macroadenomas to ectopics. J Oncol. 2012:6852132012. View Article : Google Scholar | |
Newell-Price J, Trainer P, Besser M and Grossman A: The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev. 19:647–672. 1998.PubMed/NCBI | |
Kirschner MA, Powell RD Jr and Lipsett MB: Cushing’s syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J Clin Endocrinol Metab. 24:947–955. 1964. View Article : Google Scholar : PubMed/NCBI | |
Lacroix A, Ndiaye N, Tremblay J and Hamet P: Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome. Endocr Rev. 22:75–110. 2001.PubMed/NCBI | |
Doppman JL, Chrousos GP, Papanicolaou DA, Stratakis CA, Alexander HR and Nieman LK: Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology. 216:797–802. 2000. View Article : Google Scholar : PubMed/NCBI | |
Mircescu H, Jilwan J, N’Diaye N, et al: Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing’s syndrome? J Clin Endocrinol Metab. 85:3531–3536. 2000.PubMed/NCBI | |
Bertagna X, Groussin L, Luton JP and Bertherat J: Aberrant receptor-mediated Cushing’s syndrome. Horm Res. 59(Suppl 1): 99–103. 2003. View Article : Google Scholar | |
Doppman JL, Nieman LK, Travis WD, et al: CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism. J Comput Assist Tomogr. 15:773–779. 1991. View Article : Google Scholar : PubMed/NCBI | |
Rockall AG, Babar SA, Sohaib SA, et al: CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome. Radiographics. 24:435–452. 2004. View Article : Google Scholar : PubMed/NCBI | |
Verma A, Mohan S and Gupta A: ACTH-independent macronodular adrenal hyperplasia: imaging findings of a rare condition: A case report. Abdom Imaging. 33:225–229. 2008. View Article : Google Scholar | |
Sasano H, Suzuki T and Nagura H: ACTH-independent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes. Mod Pathol. 7:215–219. 1994.PubMed/NCBI | |
Swain JM, Grant CS, Schlinkert RT, et al: Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation. Arch Surg. 133:541–546. 1998. View Article : Google Scholar : PubMed/NCBI | |
Stratakis CA and Kirschner LS: Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing’s syndrome. Horm Metab Res. 30:456–463. 1998. View Article : Google Scholar : PubMed/NCBI | |
Boronat M, Lucas T, Barcelo B, Alameda C, Hotait H and Estrada J: Cushing’s syndrome due to autonomous macronodular adrenal hyperplasia: long-term follow-up after unilateral adrenalectomy. Postgrad Med J. 72:614–616. 1996. View Article : Google Scholar : PubMed/NCBI | |
Imöhl M, Köditz R, Stachon A, et al: Catecholamine-dependent hereditary Cushing’s syndrome - follow-up after unilateral adrenalectomy. Med Klin (Munich). 97:747–753. 2002.(In German). | |
Zhang Q, Dou J, Gu W, Yang G, Mu Y and Lu J: In silico analyses reveal nuclear asymmetry of spongiocytes and compact cells of adrenocorticotrophic hormone-independent macronodular adrenocortical hyperplasia. Am J Med Sci. 347:400–405. 2014. View Article : Google Scholar | |
Imai T, Kikumori T, Shibata A, Fujiwara M, Hibi Y and Nakao A: Laparoscopic adrenalectomy for incidentaloma and bilateral adrenal disease. Asian J Surg. 26:64–70. 2003. View Article : Google Scholar : PubMed/NCBI |